Establishment Labs Holdings Inc
NASDAQ:ESTA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
22.88
59.86
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Establishment Labs Holdings Inc
Revenue
Establishment Labs Holdings Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Establishment Labs Holdings Inc
NASDAQ:ESTA
|
Revenue
$153.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
Establishment Labs Holdings Inc
Revenue Breakdown
Breakdown by Geography
Establishment Labs Holdings Inc
Total Revenue:
165.2m
USD
|
EMEA (Europe / Middle East / Africa):
80.2m
USD
|
Latin America:
48.9m
USD
|
Asia-Pacific:
34m
USD
|
Other:
2.2m
USD
|
Breakdown by Segments
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc
Glance View
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. The company is headquartered in Alajuela, Alajuela and currently employs 746 full-time employees. The company went IPO on 2018-07-19. The firm is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. Its line of silicone gel-filled breast implants, branded as MotivaImplants, is the centerpiece of its MotivaImagine medical technology platform. The Company’s MotivaImplants are sold in over 60 countries.
See Also
What is Establishment Labs Holdings Inc's Revenue?
Revenue
153.1m
USD
Based on the financial report for Sep 30, 2024, Establishment Labs Holdings Inc's Revenue amounts to 153.1m USD.
What is Establishment Labs Holdings Inc's Revenue growth rate?
Revenue CAGR 5Y
13%
Over the last year, the Revenue growth was -14%. The average annual Revenue growth rates for Establishment Labs Holdings Inc have been 9% over the past three years , 13% over the past five years .